Evidence map›Paper›PMID 39259406›Full record

ArticleCell biochemistry and biophysics2025

Effect of Extracorporeal Shock Wave on IGF-1, TNF-α, and IL-1in Joint Fluid of Patients with Temporomandibular Joint Disorder Syndrome.

Xiaotong Wei, Wei Yan, Yong Chen, Shujuan Zhao, Hao Wang, Zhizhengrong Tian, Fengyun Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biochemistry and biophysics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaotong WeiDepartment of Oral and Maxillofacial Surgery, Cangzhou Central Hospital, Cangzhou, China. weixiaotong0820@163.com.
Wei YanDepartment of Oral and Maxillofacial Surgery, Cangzhou Central Hospital, Cangzhou, China.
Yong ChenDepartment of Oral and Maxillofacial Surgery, Cangzhou Central Hospital, Cangzhou, China.
Shujuan ZhaoDepartment of Oral and Maxillofacial Surgery, Cangzhou Central Hospital, Cangzhou, China.
Hao WangDepartment of Oral and Maxillofacial Surgery, Cangzhou Central Hospital, Cangzhou, China.
Zhizhengrong TianUltrasound Department, Cangzhou Central Hospital, Cangzhou, China.
Fengyun ZhaoUltrasound Department, Cangzhou Maternal and Child Health Care Hospital, Cangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a new therapeutic method, extracorporeal shock wave (ESW) has shown remarkable efficacy in the treatment of temporomandibular joint disorder syndrome. Numerous studies have shown that it has the advantages of noninvasiveness, short treatment time, etc. It can effectively relieve pain and improve symptoms such as joint mobility and opening degree. In clinical practice, through accurate diagnosis and positioning of different patients, appropriate treatment parameters such as therapeutic transducer, frequency and pressure can be selected to significantly improve the efficacy. At the same time, follow-up evaluation after treatment, including temporomandibular joint disorder index and visual analogue score, is also helpful to fully understand the rehabilitation of patients. Extracorporeal shock wave therapy (ESWT) brings new hope to patients with temporomandibular joint disorder syndrome and has a broad application prospect.

Indexed as

Extracorporeal Shockwave TherapyInsulin-Like Growth Factor IInterleukin-1Synovial FluidTemporomandibular Joint DisordersTumor Necrosis Factor-alphaAdultFemaleHumansMaleMiddle AgedIGF1 protein, humanInsulin-Like Growth Factor IInterleukin-1Tumor Necrosis Factor-alphaExtracorporeal shock waveIGF-1IL-1βTemporomandibular joint disorder syndromeTNF-α

Identifiers

PMID39259406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.